EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes



Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes



Immunology Letters 70(3): 185-189



Helicobacter pylori is a gram-negative bacterium affecting about half of the world population, causing chronic gastritis type B dominated by activated phagocytes. In some patients the disease evolves into gastric ulcer, duodenal ulcer, gastric cancer or MALT lymphoma. The pathogenesis is in part caused by the immunological response. In mouse models and in human disease, the mucosal immune response is characterized by activated phagocytes. Mucosal T-lymphocytes are producing IFN-gamma thus increasing mucosal inflammation and mucosal damage. A low dietary intake of antioxidants such as carotenoids and vitamin C may be an important factor for acquisition of H. pylori by humans. Dietary antioxidants may also affect both acquisition of the infection and the bacterial load of H. pylori infected mice. Antioxidants, including carotenoids, have anti-inflammatory effects. The aim of the present study was to investigate whether dietary antoxidant induced modulation of H. pylori in mice affected the cytokines produced by H. pylori specific T-cells. We found that treatment of H. pylori infected mice with an algal cell extract containing the antioxidant astaxanthin reduces bacterial load and gastric inflammation. These changes are associated with a shift of the T-lymphocyte response from a predominant Th1-response dominated by IFN-gamma to a Th1/Th2-response with IFN-gamma and IL-4. To our knowledge, a switch from a Th1-response to a mixed Th1/Th2-response during an ongoing infection has not been reported previously.

(PDF emailed within 0-6 h: $19.90)

Accession: 047829804

Download citation: RISBibTeXText

PMID: 10656672

DOI: 10.1016/s0165-2478(99)00145-5



Related references

Dietary antioxidant reduces bacterial load, gastric inflammation and induces IL-4 production in H pylori infected mice. Gut 45(SUPPL 3): A38, Sept, 1999

Treatment of Helicobacter pylori infected mice with Bryophyllum pinnatum, a medicinal plant with antioxidant and antimicrobial properties, reduces bacterial load. Pharmaceutical Biology 55(1): 603-610, 2017

Treatment of H pylori infected Balb/cA mice with an antioxidant is associated with a switch from Th1 to a mixed Th1/Th2 type T-cell response and reduction of bacterial load. Abstracts Of The General Meeting Of The American Society For Microbiology. 99: 287, 1999

Helicobacter pylori chemotaxis modulates inflammation and bacterium-gastric epithelium interactions in infected mice. Infection and Immunity 75(8): 3747-3757, 2007

Standardized ginger (Zingiber officinale) extract reduces bacterial load and suppresses acute and chronic inflammation in Mongolian gerbils infected with cagAHelicobacter pylori. Pharmaceutical Biology 47(1): 92-98, 2009

Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Digestive Diseases and Sciences 49(7/8): 1095-1102, 2004

Increased inflammation and a reduced H pylori load in the gastric mucosa of IL-10-/- mice A role for inflammation in H pylori immunity?. Gastroenterology 122(4 Suppl 1): A 10, April, 2002

Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen. Experimental Parasitology 181: 7-13, 2017

Cytokine gene polymorphisms influence mucosal cytokine secretion, gastric inflammation and bacterial phenotype selection in Helicobacter pylori infection. Helicobacter 8(4): 491, August, 2003

Bacterial load and degree of gastric mucosal inflammation in Helicobacter pylori infection. Digestive Diseases 29(6): 592-599, 2012

Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infection and Immunity 67(9): 4594-4602, 1999

Gastric mucosal cytokine responses in Helicobacter pylori-infected patients with gastritis and peptic ulcers. Association with inflammatory parameters and bacteria load. FEMS Immunology & Medical Microbiology 36(3): 175-180, 2003

Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice. Letters in Applied Microbiology 48(5): 517-522, 2009

Bacterial load and inflammation in fetal tissues is not dependent on IL-17a or IL-22 in 10-14 day pregnant mice infected with Listeria monocytogenes. Microbial Pathogenesis 56: 47-52, 2013

Roles of two isoforms of cyclooxygenase and prostaglandin e2 in gastric mucosal inflammation in mice infected with helicobacter pylori. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No M2041, 2003